Attilio Olivieri

7.5k total citations · 1 hit paper
156 papers, 3.6k citations indexed

About

Attilio Olivieri is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Attilio Olivieri has authored 156 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Hematology, 53 papers in Oncology and 34 papers in Genetics. Recurrent topics in Attilio Olivieri's work include Hematopoietic Stem Cell Transplantation (65 papers), Acute Myeloid Leukemia Research (30 papers) and Multiple Myeloma Research and Treatments (30 papers). Attilio Olivieri is often cited by papers focused on Hematopoietic Stem Cell Transplantation (65 papers), Acute Myeloid Leukemia Research (30 papers) and Multiple Myeloma Research and Treatments (30 papers). Attilio Olivieri collaborates with scholars based in Italy, United States and Germany. Attilio Olivieri's co-authors include Pietro Leoni, Massimo Offidani, Antonella Poloni, Mauro Montanari, Andrea Bacigalupo, Laura Corvatta, Marino Brunori, Luigi Manzione, Alessandro Rambaldi and Paolo Corradini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Attilio Olivieri

144 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

2015 280 citations Attilio Olivieri et al. Biology of Blood and Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Attilio Olivieri Italy	33	2.2k	1.1k	801	680	580	156	3.6k
H M Lazarus United States	29	1.7k 0.8×	1.3k 1.2×	531 0.7×	1.1k 1.6×	435 0.8×	66	3.8k
Pietro Leoni Italy	34	1.7k 0.8×	745 0.7×	463 0.6×	989 1.5×	397 0.7×	128	3.4k
Meinolf Suttorp Germany	32	2.6k 1.1×	944 0.9×	951 1.2×	1.2k 1.8×	287 0.5×	184	4.0k
Antonella Santucci Italy	14	1.5k 0.7×	709 0.6×	1.0k 1.3×	363 0.5×	549 0.9×	22	3.0k
Lloyd E. Damon United States	27	1.5k 0.7×	932 0.9×	375 0.5×	970 1.4×	893 1.5×	110	3.8k
John M. McCarty United States	23	1.8k 0.8×	983 0.9×	856 1.1×	365 0.5×	238 0.4×	70	3.6k
Kazimierz Kuliczkowski Poland	29	1.2k 0.5×	1.2k 1.1×	978 1.2×	1.1k 1.6×	794 1.4×	202	3.5k
Chan‐Jeoung Park South Korea	26	1.2k 0.5×	579 0.5×	458 0.6×	502 0.7×	233 0.4×	184	2.4k
Agostino Cortelezzi Italy	36	2.0k 0.9×	586 0.5×	825 1.0×	1.8k 2.6×	891 1.5×	189	4.2k
Luen Bik To Australia	30	2.4k 1.1×	1.7k 1.5×	759 0.9×	751 1.1×	207 0.4×	78	3.9k

Countries citing papers authored by Attilio Olivieri

Since Specialization

Citations

This map shows the geographic impact of Attilio Olivieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attilio Olivieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attilio Olivieri more than expected).

Fields of papers citing papers by Attilio Olivieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attilio Olivieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attilio Olivieri. The network helps show where Attilio Olivieri may publish in the future.

Co-authorship network of co-authors of Attilio Olivieri

This figure shows the co-authorship network connecting the top 25 collaborators of Attilio Olivieri. A scholar is included among the top collaborators of Attilio Olivieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attilio Olivieri. Attilio Olivieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morsia, Erika, et al.. (2024). Is There a Correlation Between Immune Thrombocytopenia and Immunoglobulin G4-Related Disease?. Journal of Hematology. 13(4). 174–177.

Morsia, Erika, et al.. (2024). Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights. International Journal of Molecular Sciences. 25(3). 1524–1524. 3 indexed citations

Guerra, Federico, Alice Frangione, Giorgia Mancini, et al.. (2023). Cardiovascular complications of chimeric antigen receptor (CAR)-T cell therapy. European Heart Journal. 44(Supplement_2).

Morsia, Erika, Gaia Goteri, Elena Torre, et al.. (2021). Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report. SHILAP Revista de lepidopterología. 15. 100243–100243. 2 indexed citations

Saraceni, Francesco, Myriam Labopin, Édouard Forcade, et al.. (2020). Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer Medicine. 10(1). 23–33. 9 indexed citations

Chiusolo, Patrizia, Gesine Bug, Attilio Olivieri, et al.. (2018). A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study. Biology of Blood and Marrow Transplantation. 24(6). 1243–1249. 43 indexed citations

Milone, Giuseppe, Massimo Martino, Salvatore Leotta, et al.. (2017). Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma. Leukemia & lymphoma. 59(1). 42–48. 11 indexed citations

Martino, Massimo, Roberto M. Lemoli, Corrado Girmenia, et al.. (2016). Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma. Bone Marrow Transplantation. 51(8). 1032–1040. 16 indexed citations

Martino, Massimo, Mauro Montanari, Felicetto Ferrara, et al.. (2014). Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study. Biology of Blood and Marrow Transplantation. 20(7). 1026–1032. 24 indexed citations

10.

Mariotti, Jacopo, Francesco Maura, Francesco Spina, et al.. (2014). Impact of Cytomegalovirus Replication and Cytomegalovirus Serostatus on the Outcome of Patients with B Cell Lymphoma after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(6). 885–890. 32 indexed citations

11.

Olivieri, Jacopo, Luca Pierelli, Martino Introna, et al.. (2013). Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey. Cytotherapy. 16(1). 101–110. 3 indexed citations

12.

Attolico, Immacolata, Vincenzo Pavone, Angelo Ostuni, et al.. (2011). Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma. Biology of Blood and Marrow Transplantation. 18(2). 241–249. 47 indexed citations

13.

Patriarca, Francesca, Alessandra Sperotto, Daniela Damiani, et al.. (2004). Infliximab treatment for steroid-refractory acute graft-versus-host disease.. PubMed. 89(11). 1352–9. 102 indexed citations

14.

Santini, Gino, Cármino Antônio De Souza, Savina Aversa, et al.. (2004). A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group. Brazilian Journal of Medical and Biological Research. 37(5). 719–728. 1 indexed citations

15.

Majolino, Ignazio, Paolo Corradini, Rosanna Scimè, et al.. (2003). High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors. Bone Marrow Transplantation. 31(9). 767–773. 12 indexed citations

16.

Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (1999). Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplantation. 24(10). 1079–1087. 53 indexed citations

17.

Olivieri, Attilio, Antonella Poloni, Mauro Montanari, et al.. (1997). Pharmacologic Bone Marrow Purging: Is There Any Place for Etoposide? In Vitro Comparison with Mafosfamide. Journal of Hematotherapy. 6(2). 137–144. 5 indexed citations

18.

Olivieri, Attilio, et al.. (1995). Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization.. PubMed. 16(6). 765–70. 25 indexed citations

19.

Olivieri, Attilio, et al.. (1992). LE IMMUNOGLOBULINE ANTI-RH NELLE ANEMIE EMOLITICHE AUTOIMMUNI REFRATTARIE. Haematologica. 77. 35–37. 1 indexed citations

20.

Menichella, G, Luca Pierelli, Alfredo Dragani, et al.. (1990). A preliminary survey of Italian experience on bone marrow harvesting, processing and manipulation. Haematologica. 75. 39–42. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact